KR100734944B1 - Functional food-composition with calcium lactate and rice bran - Google Patents
Functional food-composition with calcium lactate and rice bran Download PDFInfo
- Publication number
- KR100734944B1 KR100734944B1 KR1020070004165A KR20070004165A KR100734944B1 KR 100734944 B1 KR100734944 B1 KR 100734944B1 KR 1020070004165 A KR1020070004165 A KR 1020070004165A KR 20070004165 A KR20070004165 A KR 20070004165A KR 100734944 B1 KR100734944 B1 KR 100734944B1
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- parts
- vitamin
- rice bran
- calcium lactate
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 18
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 title claims abstract description 11
- 235000011086 calcium lactate Nutrition 0.000 title claims abstract description 11
- 239000001527 calcium lactate Substances 0.000 title claims abstract description 11
- 229960002401 calcium lactate Drugs 0.000 title claims abstract description 11
- 235000007164 Oryza sativa Nutrition 0.000 title claims abstract description 10
- 235000009566 rice Nutrition 0.000 title claims abstract description 10
- 240000007594 Oryza sativa Species 0.000 title 1
- 102000004190 Enzymes Human genes 0.000 claims abstract description 18
- 108090000790 Enzymes Proteins 0.000 claims abstract description 18
- 235000021329 brown rice Nutrition 0.000 claims abstract description 18
- 241000209094 Oryza Species 0.000 claims abstract description 9
- 239000000843 powder Substances 0.000 claims abstract description 7
- 239000002775 capsule Substances 0.000 claims abstract description 6
- 239000000284 extract Substances 0.000 claims abstract description 4
- 239000008187 granular material Substances 0.000 claims abstract description 4
- 239000003826 tablet Substances 0.000 claims abstract description 4
- 235000013402 health food Nutrition 0.000 claims description 13
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 claims description 11
- 241000894006 Bacteria Species 0.000 claims description 7
- 235000013361 beverage Nutrition 0.000 claims description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract description 21
- 235000010755 mineral Nutrition 0.000 abstract description 21
- 239000011707 mineral Substances 0.000 abstract description 21
- 239000011575 calcium Substances 0.000 abstract description 16
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract description 15
- 229960005069 calcium Drugs 0.000 abstract description 15
- 229910052791 calcium Inorganic materials 0.000 abstract description 15
- 235000013305 food Nutrition 0.000 abstract description 15
- 229940088594 vitamin Drugs 0.000 abstract description 12
- 229930003231 vitamin Natural products 0.000 abstract description 12
- 235000013343 vitamin Nutrition 0.000 abstract description 12
- 239000011782 vitamin Substances 0.000 abstract description 12
- 239000004470 DL Methionine Substances 0.000 abstract description 4
- FFEARJCKVFRZRR-UHFFFAOYSA-N methionine Chemical compound CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 abstract description 4
- 235000006109 methionine Nutrition 0.000 abstract description 4
- 229930182817 methionine Natural products 0.000 abstract description 4
- 230000000694 effects Effects 0.000 abstract description 3
- 230000036541 health Effects 0.000 abstract description 3
- 206010016256 fatigue Diseases 0.000 abstract description 2
- 230000004060 metabolic process Effects 0.000 abstract description 2
- 239000013589 supplement Substances 0.000 abstract description 2
- 150000003722 vitamin derivatives Chemical class 0.000 abstract description 2
- 240000006439 Aspergillus oryzae Species 0.000 abstract 2
- 235000002247 Aspergillus oryzae Nutrition 0.000 abstract 2
- 229930003779 Vitamin B12 Natural products 0.000 abstract 2
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 abstract 2
- 235000013376 functional food Nutrition 0.000 abstract 2
- 239000011715 vitamin B12 Substances 0.000 abstract 2
- 235000019163 vitamin B12 Nutrition 0.000 abstract 2
- 208000024891 symptom Diseases 0.000 abstract 1
- 235000001465 calcium Nutrition 0.000 description 14
- 229940088598 enzyme Drugs 0.000 description 13
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 9
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 description 4
- 241000219061 Rheum Species 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 241000237502 Ostreidae Species 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 229930003270 Vitamin B Natural products 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 210000002257 embryonic structure Anatomy 0.000 description 2
- 235000020776 essential amino acid Nutrition 0.000 description 2
- 239000003797 essential amino acid Substances 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000011572 manganese Substances 0.000 description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 229910052750 molybdenum Inorganic materials 0.000 description 2
- 239000011733 molybdenum Substances 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 235000020636 oyster Nutrition 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 229940026510 theanine Drugs 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 208000006386 Bone Resorption Diseases 0.000 description 1
- 208000020084 Bone disease Diseases 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- 206010016326 Feeling cold Diseases 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 208000017657 Menopausal disease Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 208000031845 Pernicious anaemia Diseases 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 206010036618 Premenstrual syndrome Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 208000010641 Tooth disease Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 229940124532 absorption promoter Drugs 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000024279 bone resorption Effects 0.000 description 1
- 238000001354 calcination Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Natural products N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 1
- 229960002104 cyanocobalamin Drugs 0.000 description 1
- 235000000639 cyanocobalamin Nutrition 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- 125000002235 cyanocobalamin group Chemical group 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 229940079919 digestives enzyme preparation Drugs 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 235000021056 liquid food Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000012866 low blood pressure Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 230000015654 memory Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000036562 nail growth Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000011164 ossification Effects 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 208000028169 periodontal disease Diseases 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000007420 reactivation Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 235000021055 solid food Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- GPPXJZIENCGNKB-UHFFFAOYSA-N vanadium Chemical compound [V]#[V] GPPXJZIENCGNKB-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/198—Dry unshaped finely divided cereal products, not provided for in groups A23L7/117 - A23L7/196 and A23L29/00, e.g. meal, flour, powder, dried cereal creams or extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Inorganic Chemistry (AREA)
- Mycology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
칼슘(Ca), 철(Fe), 마그네슘(Mg), 망간 (Mn), 인 등을 비롯한 미네랄류, 비타민 및 효소는 생체 내에서 중요한 생리기능을 담당하는 영양소이나, 도시화에 따른 인스턴트 식품의 범람으로 현대인에 있어서는 상기의 미네랄, 비타민 및 효소의 섭취량이 절대적으로 부족한 실정이다.Minerals, vitamins, and enzymes, including calcium (Ca), iron (Fe), magnesium (Mg), manganese (Mn), and phosphorus, are important nutrients that play important physiological functions in the living body, or are flooded with instant foods due to urbanization. In modern people, the intake of minerals, vitamins and enzymes is absolutely insufficient.
이들 각종 미네랄, 비타민 및 효소의 결핍에 따라 뼈 형성과 뼈 흡수의 밸런스가 무너져서 뼈나 치아의 중요한 구성 성분인 칼슘이 감소하여 골다공증, 골절, 요통 등의 뼈 질환을 유발하거나 혹은 치아의 발육손상, 충치, 치주병(齒周病) 등의 치아질환, 어린이의 발육부진을 초래하고 있고, 또한 혈액과 피부조직의 지질 조성에 변화를 일으켜 고지혈증(hyper-lipidemia), 동맥경화증(atherosclerosis), 심장질환(heart disease) 등 심장순환기계 질환과 비만, 불안 야기, 월경전 증후군, 냉증, 갱년기 장애, 수면 장애 및 자율신경 실조증(失調症)과 같은 항상성 저하에 따른 각종 증상들이 현대병으로 등장하고 있다.The lack of minerals, vitamins, and enzymes can lead to a loss in balance between bone formation and bone resorption, leading to a reduction in calcium, an important constituent of bone and teeth, leading to bone diseases such as osteoporosis, fractures, back pain, or damage to teeth and tooth decay. , Tooth disease such as periodontal disease, and poor development of children, and also changes in lipid composition of blood and skin tissues, resulting in hyperlipidemia, atherosclerosis, and heart disease ( Various diseases such as cardiac circulatory system diseases such as heart disease, obesity, causing anxiety, premenstrual syndrome, coldness, menopausal disorders, sleep disorders, and autonomic ataxia have emerged as modern diseases.
상기와 같은 각종 미네랄, 비타민 및 효소의 부족을 해소하기 위해서 미네랄제제와 비타민제제 및 효소제제가 개발되고 있으나, 이들 제제를 복용하는 경우 단순히 식품을 섭취하는 경우보다 효과적이지만, 특정 미네랄, 비타민 및 효소의 과잉섭취로 오히려 고미네랄 혈증을 일으키는 등의 폐해도 있어 반드시 만족스러운 방법이라고는 할 수 없다.In order to solve the lack of various minerals, vitamins and enzymes as described above, mineral preparations and vitamin preparations and enzyme preparations have been developed, but taking these preparations is more effective than simply ingesting food, Excessive intake, rather than causing high-mineralemia, such as the lungs are not necessarily a satisfactory method.
이에 따라, 식품업계에서는 미네랄, 비타민 및 효소가 함유되어 있는 건강식품의 개발이 활발하게 이루어지고 있다.Accordingly, in the food industry, the development of health foods containing minerals, vitamins and enzymes is being actively made.
일례로 국내 공개특허 2006-52818호에서는 천연에 존재하거나 또는 공지의 방법으로 분리 정제한 철, 마그네슘, 구리, 아연, 셀렌, 칼슘, 칼륨, 망간, 크롬, 요드, 몰리브덴, 니켈, 바나듐 등의 미네랄 조성물과 테아닌을 분체 혼합하거나, 물 등의 용매 중에 미네랄과 테아닌을 녹여 혼합용액으로 제조하거나, 또는 그 혼합 용액을 동결 건조하여 캡슐제, 정제, 분말제, 과립제, 음료수 등으로 사용하는 방법이 개시되어 있으나, 이들 미네랄 성분들은 식품에 함유되어 있는 성분들을 이용한 것이 아니라 물리적 또는 화학적 방법을 통하여 인위적으로 분리한 것을 사용하고 있어 체내에서 잘 흡수하지 않는 문제점이 제기되고 있다.For example, in Korean Patent Laid-Open No. 2006-52818, minerals such as iron, magnesium, copper, zinc, selenium, calcium, potassium, manganese, chromium, iodine, molybdenum, nickel, and vanadium, which exist in nature or are purified by a known method. Disclosed is a method of mixing the composition with theanine in powder, dissolving minerals and theanine in a solvent such as water to prepare a mixed solution, or lyophilizing the mixed solution for use in capsules, tablets, powders, granules, beverages, and the like. However, these mineral components are not using the components contained in the food, but artificially separated by physical or chemical methods, which is a problem that does not absorb well in the body.
또한, 국내 공개특허 2006-52818호에는 인, 철, 망간, 칼륨, 구리, 몰리브덴, 요오드, 플루오르를 다량 함유하는 천연물 혹은 가공품의 미네랄 화합물 1종 또는 2종 이상에 미네랄 흡수 촉진제에 관한 발명이 개시되어 있으나, 이들 미네랄이 함유되어 있는 식품을 구체적으로 예시하고 있지 못하고 미네랄을 가공하여야 하는 단점이 있다.In addition, Korean Patent Laid-Open Publication No. 2006-52818 discloses an invention relating to a mineral absorption promoter in one or two or more mineral compounds of natural or processed products containing a large amount of phosphorus, iron, manganese, potassium, copper, molybdenum, iodine, and fluorine. However, it does not specifically illustrate the food containing these minerals, there is a disadvantage that must be processed minerals.
본 발명은 칼슘을 다량 함유하고 있는 굴 등의 패각으로부터 추출한 추출물과 DL-메티오닌, 미강, 현미, 황국균, 비타민 B12를 유효성분으로 함유하는 것을 특징으로 하는 건강식품 조성물에 관한 것으로, 종래의 발명들은 미네랄, 비타민, 효소를 각각 함유하는 식품이 주류를 이루고 있었으나, 본 발명은 이들 성분들을 동시에 함유하면서 식품으로서의 기호성이 저하되는 것을 방지하고, 섭취시의 식품의 맛, 향기, 식감 등의 풍미의 저하를 초래하지 않는 점에 특징이 있다.The present invention relates to a health food composition comprising an extract extracted from shells such as oysters containing a large amount of calcium and DL-methionine, rice bran, brown rice, rhubarb bacteria, and vitamin B 12 as an active ingredient. The food containing minerals, vitamins and enzymes, respectively, was the mainstream. However, the present invention prevents the palatability of foods from being reduced while simultaneously containing these ingredients, and the taste, flavor, texture, etc. It is characteristic in that it does not cause a fall.
본 발명자들은 각종 미네랄 및 효소와 비타민을 함유하는 식품을 개발하기 위하여 연구를 거듭한 결과, 인체 내에서 흡수율이 좋으며 액상식품이나 고상식품에 첨가하여도 식품 고유의 물성에 영향을 주지 않아 섭취시의 식품의 맛, 향기, 식감을 저하하지 않으면서도 인체에 필요한 각종 미네랄 및 비타민과 효소를 함유하는 식품을 개발하였으며, 본 발명에서는 이러한 기능성 건강식품 조성물을 제공하고자 한다.The present inventors conducted research to develop foods containing various minerals, enzymes and vitamins, and have good absorption in the human body and do not affect the intrinsic properties of foods even when added to liquid foods or solid foods. It has been developed a food containing various minerals and vitamins and enzymes necessary for the human body without degrading the taste, aroma, and texture of the food, and the present invention is to provide such a functional health food composition.
본 발명은 칼슘을 다량 함유하고 있는 굴 등의 패각으로부터 추출한 칼슘과 DL-메티오닌, 미강, 현미, 황국균, 비타민 B12를 유효성분으로 함유하는 것을 특징으로 하는 기능성 건강식품 조성물에 관한 것으로, 더욱 상세하게는 굴껍질을 800 도 이상에서 소성하여 분말화한 후 젖산과 반응시켜 제조한 젖산칼슘과 모발이나 손톱 등의 발육에 없어서는 안될 필수아미노산인 하기의 구조식을 갖는 DL-Methioine, 조단백 및 곡물류 효소를 다량 함유하고 있는 미강, 현미, 황국균과 비타민 B12를 함유하는 기능성 건강식품 조성물에 관한 것이다.The present invention relates to a functional health food composition comprising calcium and DL-methionine extracted from shells such as oysters containing a large amount of calcium, rice bran, brown rice, rhubarb bacteria and vitamin B 12 as active ingredients. For example, Calcium Lactate prepared by calcining and pulverizing the oyster shell at 800 degrees or higher and reacting with lactic acid and DL-Methioine, crude protein and cereal enzymes having the following structural formula, which are essential amino acids in the development of hair or nails, etc. The present invention relates to a functional health food composition containing a large amount of rice bran, brown rice, rhubarb and vitamin B 12 .
<화학식 1><Formula 1>
칼슘은 인간에 있어 필수 영양분으로 세계보건기구(WHO)는 칼슘의 1일 섭취량으로 성인의 경우 1000mg, 청소년은 1200∼1500mg을 섭취할 것을 권장하고 있다. 그러나, 인스턴트 식품 등의 범람에 따라 우리나라를 비롯한 대부분 선진국 국민들의 칼슘 섭취량은 WHO의 권장량에 미치지 못하여 칼슘 섭취가 크게 부족한 실정이다.Calcium is an essential nutrient for humans. The World Health Organization (WHO) recommends a daily intake of calcium of 1000 mg for adults and 1200 to 1500 mg for adolescents. However, due to the flooding of instant foods, the calcium intake of most of the developed countries, including Korea, is far short of the WHO's recommendation.
본 발명에는 자연산 굴 껍질을 700∼1300℃의 고온으로 소성하여 200~300 매쉬로 미세하게 분쇄한 후 50∼60℃의 온도에서 30∼50중량%의 젖산 수용액과 반응시켜 얻은 흰색의 젖산칼슘을 사용한다. 상기의 젖산칼슘은 일반적인 식품에 함 유되어 있는 칼슘에 비하여 인체에 흡수율이 높은 것으로 나타났다. In the present invention, a white calcium lactate obtained by baking natural oyster shell at a high temperature of 700 to 1300 ° C. and finely pulverizing it to 200 to 300 mesh and then reacting with 30 to 50% by weight aqueous lactic acid solution at a temperature of 50 to 60 ° C. use. The calcium lactate was found to have a higher absorption rate in the human body than calcium contained in general foods.
본 발명에 사용하는 DL-Methioine은 백색의 엷은 조각 결정 또는 결정성 분말로 감미가 있는 필수 아미노산으로 모발이나 손톱의 발육 촉진, 해독작용, 근육부활작용 간의 지방축적 방지 등에 효과가 있는 것으로 알려져 있다.DL-Methioine used in the present invention is an essential amino acid with sweetness as white flaky crystals or crystalline powder, and is known to be effective for promoting hair and nail growth, detoxification, and muscle accumulation between muscle reactivation.
현미를 도정하고 난 미강은 유지성분을 포함하고 있으며 탄수화물과 단백질, 다량의 식물섬유도 함유하고 있다. 식물섬유란 주로 식물체 내에 포함된 것으로서, 사람이 섭취할 경우 인체 내의 소화효소에 의해 분해되기 어려운 성분인 셀룰로스, 헤미셀룰로스, 리그닌, 펙틴 및 각종 검(Gum)물질 등을 총칭하며, 식물섬유는 그 종류에 따라 차이가 있으나, 주로 배변을 원활히 하고 장운동을 활성화시키며, 각종 성인병 예방에 도움을 주는 것으로 알려져 있다.Brown rice, which has been cultivated in brown rice, contains oils and fats, and contains carbohydrates, proteins, and large amounts of plant fiber. The plant fiber is mainly contained in the plant, and is a generic term for cellulose, hemicellulose, lignin, pectin and various gum substances, which are difficult to be decomposed by digestive enzymes in the human body when ingested by humans. Although there are differences depending on the type, it is mainly known to facilitate bowel movements, activate the bowel movements, and prevent various adult diseases.
현미는 모든 영양소가 모두 들어 있는 완전 식품이라 불릴 정도로 비타민 및 미네랄을 다량 함유고 있다. 특히 배아, 표피층은 비타민B군, 미네랄 등의 영양의 보고이다. 뿐만 아니라 암을 없애는 베타시스테롤이 배아에 함유되어 있다는 발표가 있었으며, 공해 물질을 배제하는 피틴산이 있다는 것은 이미 잘 알려진 사실이다. 현미에 포함된 주된 영양소는 표 1과 같다.Brown rice is rich in vitamins and minerals, called complete foods that contain all the nutrients. In particular, embryos and epidermal layers are reports of nutrition such as vitamin B group and minerals. In addition, there have been reports that cancer killing beta-cysterol is contained in embryos, and it is well known that phytic acid excludes pollutants. The main nutrients contained in brown rice are shown in Table 1.
현미효소는 현미를 누룩곰팡이로 발효시킨 후 콩과 칼슘을 첨가한 것으로 단백질, 탄수화물, 미네랄, 아미노산, 칼슘, 각종 비타민 B, 비타민 E가 다량 함유되어 있으며, 발효를 통해 현미보다 소화흡수율이 높은 것으로 나타났고 혈압조절작용이 있어 고혈압은 낮추고, 저혈압은 높여 혈압의 균형을 잡아 주고, 간장, 신장의 대사기능을 높여 유해물질 해독을 원활하게 하며, 장내의 이상 부패를 억제하고 혈액을 정화하여 세포, 장기에의 혈류를 좋게 하며, 신경세포의 신진대사를 좋게 하여 기억, 감정 등 신경의 전달을 원활하게 하는 기능이 있는 것으로 알려져 있다.Brown Rice Enzyme is fermented brown rice with yeast mold and added soybean and calcium. It contains a lot of protein, carbohydrate, mineral, amino acid, calcium, various vitamin B and vitamin E. It has higher digestion absorption rate than brown rice through fermentation. It has a blood pressure control action, which lowers high blood pressure, raises low blood pressure, balances blood pressure, improves metabolic function of liver and kidney, facilitates detoxification of harmful substances, inhibits abnormal rot in the intestine, purifies blood, It is known to have a function of improving blood flow to organs, and improving metabolism of nerve cells to facilitate the transmission of nerves such as memories and emotions.
<표 1> 현미에 포함된 주요성분<Table 1> Main Components in Brown Rice
황국균은 누룩 곰팡이라고도 하며, 장류 제조시 사용되는 곰팡이로 발효 배양을 통해 흰색에서 노란색, 녹색 계열의 균사가 퍼지면서 착생되고, 특유의 향취가 나면서 발효가 완성되는 균으로 동의보감 등에서 항암능력을 지니고 있는 것으로 알려져 있다.Hwangkuk bacteria, also known as yeast fungus, is a fungus used in the manufacture of soybeans. It is a fungus that grows from white to yellow and green mycelia through fermentation culture. It is known.
비타민 B12는 성분이 시아노코발라민(Cyanocobalamin)인 암적색의 분말 또는 결정의 영양강화제로 화학식은 C63H88CoN14O14P이며, 무수물은 흡습성이 강하다.Vitamin B 12 is a nutritive enhancer of a dark red powder or crystal whose component is cyanocobalamin, and the chemical formula is C 63 H 88 CoN 14 O 14 P. Anhydrides are highly hygroscopic.
비타민 B12의 수용액은 중성이며, pH4.5~6.0에서 가장 안정적이며, 알카리 조건에서 천천히 분해한다. 비타민 B12가 부족하면 거대적 아구성 빈혈과 신장 장애 를 일으키며 철분이 부족하여 생긴 빈혈과 다른 악성빈혈(pernicious anemia)이 나타난다.Aqueous solutions of vitamin B 12 are neutral, most stable at pH 4.5-6.0, and degrade slowly under alkaline conditions. Lack of vitamin B 12 leads to massive sub-blast anemia and kidney failure, iron anemia and other pernicious anemia.
본 발명의 각 성분의 조성비율은 젖산칼슘 100중량부에 대하여 DL-Methioine 1~10 중량부, 미강 0.1~5중량부, 현미효소 0.05~5중량부, 황국균 0.001~0.5중량부, 비타민 B12 0.001~0.5중량부로 이루어진다.The composition ratio of each component of the present invention is 1 to 10 parts by weight of DL-Methioine, 0.1 to 5 parts by weight of rice bran, 0.05 to 5 parts by weight of brown rice enzyme, 0.001 to 0.5 parts by weight of bacterium bacterium, and vitamin B 12 with respect to 100 parts by weight of calcium lactate. It consists of 0.001-0.5 weight part.
본 발명은 상기의 배합비율에 국한된 것은 아니지만, 상기의 비율을 벗어나는 경우 맛이나 냄새에 영향을 미치는 것으로 확인되었다. The present invention is not limited to the above compounding ratio, but it has been found to affect taste or smell when out of the above ratio.
[실시예 1]Example 1
깨끗이 세척한 10kg의 자연산 굴 껍질을 700∼1300℃의 고온으로 소성하여 200~300매쉬로 미세하게 분쇄한 후, 50∼60℃의 온도에서 30∼50중량%의 젖산 수용액 5ℓ와 반응시켜 흰색의 젖산칼슘 덩어리를 얻는다. 상기의 젖산칼슘 덩어리를 곱게 분쇄한 젖산칼슘 100g에 대하여, DL- Methioine 5g, 미강 0.85g, 현미효소 0.1g, 황국균 0.005g, 비타민 B12 0.005g를 교반기에서 30분~1시간 동안 교반, 혼합하여 기능성 건강식품 조성물을 얻었다.10 kg of freshly cleaned oyster shell washed at a high temperature of 700-1300 ° C. and finely pulverized into 200-300 mesh, and then reacted with 5 L of 30-50% by weight aqueous lactic acid solution at a temperature of 50-60 ° C. Obtain a mass of calcium lactate. To 100 g of calcium lactate finely pulverized the above calcium lactate lump, 5 g of DL-Methioine, 0.85 g of rice bran, 0.1 g of brown rice enzyme, 0.005 g of Rheum bacteria, and 0.005 g of vitamin B 12 were stirred and mixed for 30 minutes to 1 hour in a stirrer. The functional health food composition was obtained.
[실시예 2]Example 2
실시예 1의 기능성 건강식품 조성물을 통상의 정제 제조방법에 따라서 타정하여 정제를 제조하였다.Tablets were prepared by tableting the functional health food composition of Example 1 according to a conventional tablet production method.
[실시예 3]Example 3
실시예 1의 기능성 건강식품 조성물을 통상의 캡슐 제조방법에 따라서 캡슐을 제조하였다.The functional health food composition of Example 1 was prepared capsules according to the conventional capsule production method.
상기 기능성 건강식품 조성물은 통상의 제조방법에 따라 분말, 캡슐, 정제, 과립, 엑기스, 음료 등의 형태로 제형화할 수 있고, 연령, 체중에 따라 적량을 선택하여 섭취할 수 있으며, 성인의 경우 1일 2~10g의 섭취로 충분한 효과를 얻을 수 있다.The functional health food composition can be formulated in the form of powder, capsules, tablets, granules, extracts, beverages, etc. according to a conventional manufacturing method, can be ingested by selecting the appropriate amount according to age and weight, in the case of adults 1 Intake of 2 ~ 10g per day can get enough effect.
본 발명은 현대인들에게 부족하기 쉬운 칼슘, 각종 미네랄, 비타민 및 효소를 보충하여 줌으로써, 만성피로, 체질개선, 신진대사 불균형의 증상을 완화하는 효과를 기대할 수 있으므로, 기능성 건강식품으로 유용하게 사용될 수 있다.The present invention can supplement the calcium, various minerals, vitamins and enzymes that are easily lacking in modern people, and can be used as a functional health food because it can be expected to reduce the effects of chronic fatigue, constitution improvement, metabolic imbalance. have.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070004165A KR100734944B1 (en) | 2007-01-15 | 2007-01-15 | Functional food-composition with calcium lactate and rice bran |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070004165A KR100734944B1 (en) | 2007-01-15 | 2007-01-15 | Functional food-composition with calcium lactate and rice bran |
Publications (1)
Publication Number | Publication Date |
---|---|
KR100734944B1 true KR100734944B1 (en) | 2007-07-03 |
Family
ID=38503050
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020070004165A KR100734944B1 (en) | 2007-01-15 | 2007-01-15 | Functional food-composition with calcium lactate and rice bran |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100734944B1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100893661B1 (en) | 2008-03-06 | 2009-04-17 | 최성훈 | Manufacturing method of functional rice bran using enzymatic hydrolysis and vacuum drying |
CN106255420A (en) * | 2014-03-28 | 2016-12-21 | 玛鲁哈日鲁株式会社 | Citrus sarcocarp processing composition and the manufacture method using its sarcocarp to process food |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020017197A (en) | 2000-08-29 | 2002-03-07 | 최경호 | Functional food using enzyme extract and manufacturing method thereof |
KR20050053071A (en) | 2003-12-02 | 2005-06-08 | 대한민국(강릉대학교총장) | Functional food composition comprising the polysaccharide and oligosaccharide extract of laminaria for improvement and prevention of constipation |
-
2007
- 2007-01-15 KR KR1020070004165A patent/KR100734944B1/en active IP Right Review Request
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020017197A (en) | 2000-08-29 | 2002-03-07 | 최경호 | Functional food using enzyme extract and manufacturing method thereof |
KR20050053071A (en) | 2003-12-02 | 2005-06-08 | 대한민국(강릉대학교총장) | Functional food composition comprising the polysaccharide and oligosaccharide extract of laminaria for improvement and prevention of constipation |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100893661B1 (en) | 2008-03-06 | 2009-04-17 | 최성훈 | Manufacturing method of functional rice bran using enzymatic hydrolysis and vacuum drying |
CN106255420A (en) * | 2014-03-28 | 2016-12-21 | 玛鲁哈日鲁株式会社 | Citrus sarcocarp processing composition and the manufacture method using its sarcocarp to process food |
CN106255420B (en) * | 2014-03-28 | 2020-03-06 | 玛鲁哈日鲁株式会社 | Composition for processing citrus pulp and method for producing pulp-processed food using same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108272073A (en) | A kind of weight losing meal-replacing powder and preparation method thereof | |
KR101539382B1 (en) | Food composition for improvement of bowel function and relief of constipation | |
JPH09191852A (en) | Healthy food | |
CN103976023A (en) | Okra yogurt beverage and preparation method thereof | |
WO2008014674A1 (en) | A nutritional and health-care edible potassium salt with wide purpose | |
CN110771825A (en) | Comprehensive nutrition powder for reducing fat, blood sugar, blood pressure and blood fat and preparation method thereof | |
CN103371318B (en) | Dietary nutrition replenishing food | |
CN105124347A (en) | Moringa oleifera blood-glucose-reducing composition and preparation method thereof | |
KR101896024B1 (en) | Functional food compositions comprising extracts of Garcinia Cambogia as active ingredients and method for preparing the same | |
CN105707681A (en) | Supermicro black fungus nutrient porridge with blood sugar reducing function and making method thereof | |
CN105341300A (en) | Health-care candies suitable for children to eat | |
CN102018158A (en) | Aloe jam | |
KR100734944B1 (en) | Functional food-composition with calcium lactate and rice bran | |
CN101708047B (en) | Method for preparing instant seasoning jelly fungus | |
CN103609748A (en) | Hypoglycaemic milk powder for pregnant women and preparation method thereof | |
CN103271353B (en) | Liver protecting and health care composition and preparation method thereof | |
CN108851037A (en) | A kind of preparation method and its usage of nephrotic syndrome wholefood | |
CN101224005B (en) | Nutrient tablet possessing whole nutrient supplementing efficacy and producing method thereof | |
CN101129406A (en) | Formula of compound colla carapaeis corii asini series products and method for producing the same | |
CN107455699A (en) | A kind of ion Vc composition containing pawpaw and preparation method thereof | |
CN103300424A (en) | Spirulina paste and manufacturing method thereof | |
CN115702654A (en) | Middle-aged and old-aged modified goat milk powder assisting in reducing blood sugar and preparation method thereof | |
KR20100037309A (en) | Pill type manufacturing method of health supporting food | |
KR20110014418A (en) | A hot spice | |
KR20100037312A (en) | Powder type manufacturing method of health supporting food |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
A302 | Request for accelerated examination | ||
A302 | Request for accelerated examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
J202 | Request for trial for correction [limitation] | ||
J301 | Trial decision |
Free format text: TRIAL DECISION FOR CORRECTION REQUESTED 20070830 Effective date: 20071227 |
|
J302 | Written judgement (patent court) |
Free format text: JUDGMENT (PATENT COURT) FOR CORRECTION REQUESTED 20080116 Effective date: 20090424 |
|
FPAY | Annual fee payment |
Payment date: 20130412 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20140605 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20150615 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20160617 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20180625 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20190626 Year of fee payment: 13 |